Implications of Ruth Bader Ginsburg's Death for the Healthcare Industry

A team of UBS investment strategists studied how the passing of Ruth Bader Ginsberg would effect the health care industry.
UBS said Ginsburg death will increase uncertainty within the healthcare sector.
According to Business Insider they still list it as "moderately preferred" in their broader sector allocation.
Their analysis rests on the outcome of a Supreme Court decision involving the constitutionality of the individual mandate component of the ACA.
SCOTUS could completely strike down the individual mandate.
This uncertainty will likely weigh on valuations for managed care companies, said UBS.